Decoding Your Genetic Test: Understanding the Microarray Report

A genetic test report can look like a wall of technical jargon, but it is the most important document in your medical folder. To diagnose 1q21.1 microdeletion, doctors use a test called a Chromosomal Microarray (CMA) or a SNP array ^[1][2]. This test scans your child’s chromosomes for missing or extra pieces of DNA, known as copy number variants (CNVs) ^[3].

When a CMA finds a “pathogenic” CNV, it means the lab has found a missing piece of DNA that is established to cause health or developmental challenges ^[4].

The Anatomy of Your Result

Every report should contain a specific string of numbers and letters—this is the “address” of the missing DNA. To understand your report, look for these key components:

1. The Coordinates and Genome Build

The report will list a range of numbers representing where the deletion starts and ends. It must also state which “version” of the human genome map it used, typically GRCh37 (hg19) or GRCh38 (hg38) ^[5][6].

• Why this matters: The same deletion will have different coordinate numbers depending on which map version the lab used. Without the version, the numbers are like an address without a zip code.

2. Distal vs. Proximal: Which Region is Missing?

The 1q21.1 area is broadly divided into two main neighborhoods, though the exact breakpoints can vary. Your geneticist will use the laboratory’s coordinates and formal ISCN nomenclature to determine your specific deletion:

• Distal Deletion: Often described as falling between breakpoints BP3 and BP4, this is the most common form, frequently linked to developmental delays, microcephaly, and psychiatric risks ^[7][8].
• Proximal Deletion: Often described as falling between BP2 and BP3 (or BP1-BP2 depending on the lab’s naming conventions), this region contains the RBM8A gene ^[9][10]. A deletion here is evaluated for its association with TAR syndrome, though the deletion alone does not cause the syndrome ^[11].
• Class II / Larger Deletions: Some people have a large deletion that spans both regions or involves atypical (non-recurrent) breakpoints ^[9]. A genetics professional must interpret the interval rather than relying on breakpoint labels alone.

3. The Gene List

A report may list specific genes located within the missing piece, though not all labs format their reports this way. Genes that have been studied as possible contributors to the syndrome’s features include:

• GJA5 and CHD1L: Often missing in distal deletions; these have been studied as possible contributors to heart development and brain growth ^[12][13].
• RBM8A: The primary gene involved in the proximal TAR-associated region ^[10].
• PRKAB2: A gene in the distal region studied for its role in neurological health ^[14].

Caution: While gene content can help classify a CNV, it cannot predict a person’s developmental or medical outcome. Do not use the gene list as a rigid prognosis ^[15].

Questions to Ask Your Genetics Team

If you are reading your report, look for these items and ask your clinician to clarify them:

• Classification: Is it labeled Pathogenic or Likely Pathogenic? If it is listed as a VUS (Variant of Uncertain Significance), this means there is not enough evidence to say it causes health issues, and a VUS generally should not drive major medical decisions by itself.
• Size: Is the size listed in Mb (Megabases) or kb (kilobases)?
• Coordinates & Build: What are the exact coordinates, and is it hg19 or hg38?
• Inheritance: The report will only show if it is inherited after parental testing has been performed ^[7].

Why Parental Testing is the Next Step

Once a deletion is found in a child, doctors almost always recommend testing both biological parents. This is not to assign “blame,” but to provide vital context ^[16].

• If a parent has the same deletion, it helps explain inheritance and informs the risk for future pregnancies (generally a 50% transmission chance per pregnancy) ^[7][8].
• If neither parent has the deletion in the tested sample, it is usually called de novo (meaning “new”). The recurrence risk is usually very low, but not zero.

If your report is difficult to read or missing context, direct your questions to the ordering clinician or a genetic counselor to help interpret it safely.